GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (AMEX:INFU) » Definitions » Debt-to-Equity
中文

InfuSystems Holdings (InfuSystems Holdings) Debt-to-Equity

: 0.67 (As of Dec. 2023)
View and export this data going back to 1992. Start your Free Trial

InfuSystems Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.0 Mil. InfuSystems Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $34.9 Mil. InfuSystems Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $52.3 Mil. InfuSystems Holdings's debt to equity for the quarter that ended in Dec. 2023 was 0.67.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for InfuSystems Holdings's Debt-to-Equity or its related term are showing as below:

INFU' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.55   Med: 0.77   Max: 1.93
Current: 0.67

During the past 13 years, the highest Debt-to-Equity Ratio of InfuSystems Holdings was 1.93. The lowest was 0.55. And the median was 0.77.

INFU's Debt-to-Equity is ranked worse than
81.35% of 713 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs INFU: 0.67

InfuSystems Holdings Debt-to-Equity Historical Data

The historical data trend for InfuSystems Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.93 1.05 0.76 0.77 0.67

InfuSystems Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.83 0.80 0.71 0.67

Competitive Comparison

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InfuSystems Holdings Debt-to-Equity Distribution

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Debt-to-Equity falls into.



InfuSystems Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

InfuSystems Holdings's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

InfuSystems Holdings's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InfuSystems Holdings  (AMEX:INFU) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


InfuSystems Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


InfuSystems Holdings (InfuSystems Holdings) Business Description

Traded in Other Exchanges
Address
3851 West Hamlin Road, Rochester Hills, MI, USA, 48309
InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.
Executives
Jerod Funke officer: EVP-Chief HR Officer 3851 WEST HAMLIN RD, ROCHESTER HILLS MI 48309
R. Rimmy Malhotra director C/O COMMAND CENTER, INC., 3609 S WADSWORTH BLVD., SUITE 250, LAKEWOOD CO 80235
Gregg Owen Lehman director 309 HADDON COURT, FRANKLIN X1 37067
Richard Dilorio officer: Executive Vice President 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Barry G Steele officer: Executive VP and CFO 500 TOWN CENTER DR., SUITE 200, DEARBORN MI 48126
Carrie Lachance officer: Executive VP and COO 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Christopher R. Sansone director C/O SANSONE ADVISORS, LLC, 151 BODMAN PLACE, SUITE 100, RED BANK NJ 07701
Addam Chupa officer: Executive VP and CIO 3851 WEST HAMLIN ROAD, ROCHESTER HILLS MI 48309
Kevin Whitman officer: VP and Corporate Controller 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Thomas Mark Ruiz officer: VP of Sales and Marketing 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Boyd Ralph F Jr director
Paul Andrew Gendron director 740 BANDIT TRAIL, KELLER TX 76248
Jeannine Sheehan officer: Chief Administrative Officer 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Blueline Capital Partners Ii, L.p. director 3480 BUSKIRK AVENUE, SUITE 214, PLEASANT HILL CA 94523
Meridian Tsv Ii, Lp 10 percent owner 405 WEED STREET, NEW CANAAN CT 06840